Despite substantial investments in artificial intelligence, large-scale implementation remains the exception rather than the rule in healthcare. According to KPMG’s Global Healthcare CEO Outlook 2026, only 2% of surveyed healthcare organisations have fully integrated AI into their core clinical and operational processes. Meanwhile, 91% of healthcare executives expect their workforce to grow over the next three years. The findings suggest that the next phase of AI adoption will require fundamental changes to care delivery, continued investment in digital infrastructure and a greater focus on workforce development.
KPMG surveyed 100 healthcare CEOs as part of a global study involving 1,400 executives across 12 markets. The results indicate that healthcare organisations are making progress with AI, but that relatively few have achieved enterprise-wide transformation.
From AI adoption to healthcare transformation
Among respondents, 52% report deploying AI across multiple areas, with tangible positive results beginning to emerge. Another 41% are experimenting with AI or using it selectively, with limited impact. Five percent have integrated AI into digital and virtual care pathways, while just 2% report fully scaled implementation with measurable benefits across core workflows.
Investment ambitions are considerably more advanced. Some 83% of healthcare executives identify AI as a major investment priority over the next three years, while 23% expect to achieve a return on investment within six to twelve months. According to Beccy Fenton, Global Head of Healthcare at KPMG International, the challenge is to move beyond individual applications and fundamentally redesign healthcare delivery.
AI-powered clinical documentation, for example, can reduce administrative workloads without necessarily enabling clinicians to treat more patients. Achieving additional capacity requires changes to the entire care pathway, from prevention and diagnosis to treatment, recovery and follow-up. Only when time savings are effectively redeployed and existing bottlenecks are addressed can AI contribute to greater healthcare capacity.
AI is changing workforce requirements
One of the report's most striking findings is that 91% of healthcare executives expect their workforce to increase over the next three years. This appears to contradict expectations that AI will replace certain jobs. However, 29% anticipate AI-related workforce reductions within the next twelve months, while 59% expect reductions in particular organisational areas over the following two to five years. These developments are not necessarily contradictory. While AI may automate or transform administrative and supporting tasks, demand for employees in other areas could continue to grow.
Skills shortages remain a significant concern, with 58% of executives identifying gaps in workforce capabilities as a major challenge. For 83%, AI has already prompted a reassessment of the skills required for entry-level positions. Workforce development is consequently becoming a strategic priority. Eighty-four percent of organisations are focusing on employee retention and retraining, while 78% are recruiting staff with AI and technology expertise, compared with 56% in 2025.
The findings underline that digital healthcare transformation cannot be separated from workforce planning. Introducing new technologies also requires investment in professional development, new competencies and different ways of working.
Data quality and infrastructure remain obstacles
Another challenge concerns the availability and quality of healthcare data. Although 81% of executives express confidence in their organisation's data readiness for AI, 45% still identify data quality and availability as obstacles to implementation. Additionally, 62% report placing greater emphasis on internal data governance and control because of AI adoption and increasing data sovereignty requirements. Chris Gibbons, Global Healthcare AI Lead at KPMG International, emphasises that sustainable AI implementation depends on continued investment in underlying digital platforms.
For healthcare providers, this means that interoperability, secure data exchange and reliable information systems are essential foundations for scaling AI. These considerations are particularly relevant in Europe, where the development of the European Health Data Space (EHDS) is expected to support more consistent access to and exchange of health information. Digital resilience is also becoming increasingly important. More than half of respondents (55%) identify improved threat detection and security as one of AI's leading benefits.
Meanwhile, 51% regard end-to-end supply chain visibility, supported by data and digital technologies, as a major priority. As healthcare organisations become more dependent on digital infrastructure, maintaining continuity of care during cyberattacks, technical failures or disruptions involving technology suppliers becomes an increasingly important consideration.
Scaling AI requires strategic leadership
For healthcare organisations worldwide, the report highlights that successful digital transformation involves considerably more than introducing individual AI applications. Reducing administrative workloads does not automatically translate into shorter waiting times, improved accessibility or sustainable reductions in staff pressure. Achieving these outcomes requires healthcare organisations to evaluate the effects of AI across entire care pathways.
These challenges will also feature prominently at the ICT&health World Conference 2027, taking place in Maastricht, the Netherlands, from 26 to 28 January. Healthcare executives, professionals, researchers, policymakers and technology companies will discuss how AI and digital innovation can deliver measurable improvements in healthcare.
The KPMG findings suggest that the next stage of AI adoption will not be defined by the number of applications deployed. The greater challenge is connecting technology, workforce development and redesigned care processes to achieve sustainable improvements for patients and healthcare professionals.
The study is based on responses from 100 healthcare CEOs representing organisations with annual revenues exceeding US$500 million. Conducted between 11 August and 21 September 2026 across twelve markets, the survey reflects executives' experiences and expectations rather than independently verified clinical outcomes.
References
Add ICT&health on Google
Show more content from ICT&health in Google Search.